CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 8-K Event Results of operations
- 4 Planned sale CHIEF OPERATING OFFICER sold 23,017 shares at $20.44 ($470,467)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 27,829 shares at an average $21.34 ($593,997)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 15,116 shares at an average $21.37 ($323,009)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 8,646 shares at $22.45 ($194,103)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 17,000 shares at $21.04 ($357,680)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Director acquired 1,303 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale CHAIRMAN & CEO sold 89,561 shares at $23.00 ($2,059,903)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
Page 14 of 39 · 778 filings